The no-reflow phenomenon associated with percutaneous coronary intervention: its mechanisms and treatment

By Ito Hiroshi  

Cardiovascular Intervention and Therapeutics, Vol. 26, Iss. 1, 2011-01 ,pp. : 2-11

Springer Publishing Company

Access to resources Recommend Favorite

Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention

By Smith Simon M.G.   Judge Heather M.   Peters Gary   Storey Robert F.  

Platelets, Vol. 15, Iss. 8, 2004-12 ,pp. : 465-474

Informa Healthcare

Access to resources Recommend Favorite

Percutaneous Coronary Intervention in Diabetics

By Karha Juhana   Bhatt Deepak L.  

Reviews in Endocrine and Metabolic Disorders, Vol. 5, Iss. 3, 2004-08 ,pp. : 277-285

Springer Publishing Company

Access to resources Recommend Favorite

Effect of High‐Dose Statin Pretreatment on the Incidence of Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention: Grading the Evidence Through a Cumulative Meta‐analysis

By  

Clinical Cardiology, Vol. 38, Iss. 11, 2015-11 ,pp. : 668-678

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of early abciximab administration on myocardial reperfusion in patients with ST-segment elevation myocardial infarction pretreated with 600 mg of clopidogrel before percutaneous coronary intervention

By Dudek Dariusz   Rakowski Tomasz   Bartus Stanislaw   Giszterowicz Dawid   Dobrowolski Wojciech   Zmudka Krzysztof   Zalewski Jaroslaw   Ochala Andrzej   Wieja Pawel   Janus Bogdan   Dziewierz Artur   Legutko Jacek   Bryniarski Leszek   Dubiel Jacek  

Journal of Thrombosis and Thrombolysis, Vol. 30, Iss. 3, 2010-10 ,pp. : 347-353

Springer Publishing Company

Access to resources Recommend Favorite